Does the FDA have regulatory authority over adult autologous stem cell therapies? 21 CFR 1271 and the emperor's new clothes.
about
Examination of the regulatory frameworks applicable to biologic drugs (including stem cells and their progeny) in Europe, the U.S., and Australia: part I--a method of manual documentary analysis.Cell therapy worldwide: an incipient revolution.Platforms for Manufacturing Allogeneic, Autologous and iPSC Cell Therapy Products: An Industry Perspective.
P2860
Does the FDA have regulatory authority over adult autologous stem cell therapies? 21 CFR 1271 and the emperor's new clothes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Does the FDA have regulatory a ...... and the emperor's new clothes.
@en
type
label
Does the FDA have regulatory a ...... and the emperor's new clothes.
@en
prefLabel
Does the FDA have regulatory a ...... and the emperor's new clothes.
@en
P2860
P356
P1476
Does the FDA have regulatory a ...... and the emperor's new clothes
@en
P2093
Mitchell Fuerst
P2860
P2888
P356
10.1186/1479-5876-10-60
P577
2012-03-26T00:00:00Z
P5875
P6179
1051791121